{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T07:14:05Z","timestamp":1781680445467,"version":"3.54.5"},"reference-count":126,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1685,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1111\/j.1365-2036.2011.04579.x","type":"journal-article","created":{"date-parts":[[2011,1,21]],"date-time":"2011-01-21T01:14:36Z","timestamp":1295572476000},"page":"801-814","source":"Crossref","is-referenced-by-count":108,"title":["Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease"],"prefix":"10.1111","volume":"33","author":[{"given":"A.","family":"Baranova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. P.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Birerdinc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z. M.","family":"Younossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,1,20]]},"reference":[{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1001\/archinte.166.19.2081","article-title":"Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women","volume":"166","author":"Alvarez-Blasco","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.2337\/diacare.14.12.1132","article-title":"Metabolic implications of body fat distribution","volume":"14","author":"Bj\u00f6rntorp","year":"1991","journal-title":"Diab Care"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diabetes.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.med.56.082103.104751","article-title":"Metabolic syndrome: a clinical and molecular perspective","volume":"56","author":"Moller","year":"2005","journal-title":"Annu Rev Med"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.OGX.0000109523.25076.E2","article-title":"Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls","volume":"59","author":"Legro","year":"2004","journal-title":"Obstet Gynecol Surv"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2265.1990.tb00857.x","article-title":"Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases","volume":"32","author":"Kiddy","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/09513590802342858","article-title":"Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome","volume":"24","author":"Kulshreshtha","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2265.2008.03247.x","article-title":"Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)","volume":"69","author":"Diamanti-Kandarakis","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/09513590802653833","article-title":"Serum resistin and adiponectin levels in women with polycystic ovary syndrome","volume":"25","author":"Yilmaz","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.metabol.2009.02.022","article-title":"Evidence of proatherogenic inflammation in polycystic ovary syndrome","volume":"58","author":"Gonz\u00e1lez","year":"2009","journal-title":"Metabolism"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2119\/molmed.2009.00118","article-title":"Changes in the expression of insulin signaling pathway molecules in endometria from polycystic ovary syndrome women with or without hyperinsulinemia","volume":"16","author":"Fornes","year":"2010","journal-title":"Mol Med"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"527850","DOI":"10.1155\/2010\/527850","article-title":"Skeletal muscle insulin resistance in endocrine disease","volume":"2010","author":"Peppa","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB15|cit15","first-page":"743","article-title":"Molecular & genetic factors contributing to insulin resistance in polycystic ovary syndrome","volume":"131","author":"Mukherjee","year":"2010","journal-title":"Indian J Med Res"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12199-008-0074-5","article-title":"Prevalence of nonalcoholicfatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference","volume":"14","author":"Tominaga","year":"2009","journal-title":"Environ Health Prev Med"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3949\/ccjm.75.10.721","article-title":"Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome","volume":"75","author":"Kim","year":"2008","journal-title":"Cleveland Clin J Med"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/gut.2009.205088","article-title":"Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3\u2003years","volume":"59","author":"Wong","year":"2010","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MAJ.0b013e3181812879","article-title":"Effect of body weight and lifestyle changes on long-term course of nonalcoholic fatty liver disease in Koreans","volume":"337","author":"Kim","year":"2009","journal-title":"Am J Med Sci"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","article-title":"Long-term follow-up of patients with nonalcoholic fatty liver","volume":"7","author":"Rafiq","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1136\/gut.2010.213553","article-title":"Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study","volume":"59","author":"Stepanova","year":"2010","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2001-12927","article-title":"Etiopathogenesis of nonalcoholic steatohepatitis","volume":"21","author":"Chitturi","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/01.mol.0000174153.53683.f2","article-title":"Nonalcoholic fatty liver disease and the metabolic syndrome","volume":"16","author":"Marchesini","year":"2005","journal-title":"Curr Opin Lipidol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB24|cit24","first-page":"41","article-title":"The metabolic syndrome and nonalcoholic fatty liver disease","volume":"48","author":"Collantes","year":"2006","journal-title":"Panminerva Med"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ajg.2009.67","article-title":"NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study","volume":"104","author":"Adams","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4158\/EP.11.5.319","article-title":"Polycystic ovary syndrome and severe nonalcoholic steatohepatitis: beneficial effect of modest weight loss and exercise on liver biopsy findings","volume":"11","author":"Brown","year":"2005","journal-title":"Endocr Pract"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/humrep\/dep380","article-title":"Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"25","author":"Vassilatou","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cgh.2006.10.010","article-title":"Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"5","author":"Gambarin-Gelwan","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2007.04.012","article-title":"Nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"47","author":"Cerda","year":"2007","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2005-2774","article-title":"Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome","volume":"91","author":"Setji","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1440-1746.2008.05740.x","article-title":"An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome","volume":"24","author":"Brzozowska","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.fertnstert.2008.12.008","article-title":"Hepatic steatosis in young lean insulin resistant women with polycystic ovary syndrome","volume":"93","author":"Markou","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"12587","DOI":"10.1073\/pnas.0705408104","article-title":"The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome","volume":"104","author":"Petersen","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.nutr.012809.104726","article-title":"The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome","volume":"30","author":"Jornayvaz","year":"2010","journal-title":"Annu Rev Nutr"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.metabol.2003.10.032","article-title":"Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals","volume":"53","author":"McLaughlin","year":"2004","journal-title":"Metabolism"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2006.06.013","article-title":"Hepatic histology in obese patients undergoing bariatric surgery","volume":"45","author":"Machado","year":"2006","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1440-1746.2010.06253.x","article-title":"A fresh look at NASH pathogenesis. Part 1: the metabolic movers","volume":"25","author":"Larter","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000293493","article-title":"Familial clustering in the polycystic ovarian syndrome","volume":"28","author":"Lunde","year":"1989","journal-title":"Gynec Obstet Invest"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0889-8529(18)30409-2","article-title":"Familial polycystic ovarian disease","volume":"17","author":"Givens","year":"1988","journal-title":"Endocr Metab Clin N Am"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/humupd\/dmn024","article-title":"Functional genetic polymorphisms and female reproductive disorders: Part I: polycystic ovary syndrome and ovarian response","volume":"14","author":"Simoni","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB41|cit41","doi-asserted-by":"crossref","DOI":"10.1155\/2007\/49109","article-title":"The genetic basis of the polycystic ovary syndrome: a literature review including discussion of PPAR-gamma","volume":"2007","author":"Unluturk","year":"2007","journal-title":"PPAR Res"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/humrep\/den065","article-title":"Small glutamine-rich tetratricopeptide repeat containing protein alpha (SGTA), a candidate gene for polycystic ovary syndrome","volume":"23","author":"Goodarzi","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2350-11-12","article-title":"Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS)","volume":"11","author":"Tan","year":"2010","journal-title":"BMC Med Genet"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1210\/jc.2006-1665","article-title":"Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome","volume":"92","author":"Cort\u00f3n","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1530\/eje.1.02207","article-title":"Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls","volume":"155","author":"Glintborg","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1742-4682-6-18","article-title":"Construction of a polycystic ovarian syndrome (PCOS) pathway based on the interactions of PCOS-related proteins retrieved from bibliomic data","volume":"6","author":"Mohamed-Hussein","year":"2009","journal-title":"Theor Biol Med Model"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/6.3.397","article-title":"Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism","volume":"6","author":"Gharani","year":"1997","journal-title":"Hum Molec Genet"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1152\/physiolgenomics.00193.2004","article-title":"Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects","volume":"20","author":"Wood","year":"2005","journal-title":"Physiol Genomics"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1210\/me.2007-0513","article-title":"Role of the GATA family of transcription factors in endocrine development, function, and disease","volume":"22","author":"Viger","year":"2008","journal-title":"Mol Endocrinol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1194\/jlr.M200327-JLR200","article-title":"Fenofibrate, a ligand for PPARalpha, inhibits aromatase cytochrome P450 expression in the ovary of mouse","volume":"44","author":"Toda","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/oby.2008.661","article-title":"Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate","volume":"17","author":"Forcheron","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1210\/jc.85.6.2304","article-title":"Differential activity of the cytochrome P450 17-alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells","volume":"85","author":"Wickenheisser","year":"2000","journal-title":"J Clin Endocr Metab"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB53|cit53","first-page":"143","article-title":"Conditions for functional, long-term human theca interna and granulosa cell cultures from polycystic ovaries","volume":"136","author":"McAllister","year":"1995","journal-title":"Endocrinology"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.metabol.2008.08.002","article-title":"Polymorphism T --> C (-34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study","volume":"57","author":"Echibur\u00fa","year":"2008","journal-title":"Metabolism"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mce.2008.01.007","article-title":"Role of adiponectin in regulating ovarian theca and granulosa cell function","volume":"284","author":"Lagaly","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/BF03346454","article-title":"Increased clearance of cortisol by 5beta-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome","volume":"32","author":"Gambineri","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0140-6736(90)90664-Q","article-title":"5-Alpha-reductase activity in polycystic ovary syndrome","volume":"335","author":"Stewart","year":"1990","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1210\/jc.84.7.2414","article-title":"5-alpha-reductase activity in women with polycystic ovary syndrome","volume":"84","author":"Jakimiuk","year":"1999","journal-title":"J Clin Endocr Metab"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1210\/jc.2009-0837","article-title":"Increased 5 alpha-reductase activity and adrenocortical drive in women with polycystic ovary syndrome","volume":"94","author":"Vassiliadi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.fertnstert.2007.12.082","article-title":"A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome","volume":"91","author":"Glintborg","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.2337\/db08-0094","article-title":"Reduced glucocorticoid production rate, decreased 5alpha-reductase activity, and adipose tissue insulin sensitization after weight loss","volume":"57","author":"Tomlinson","year":"2008","journal-title":"Diabetes"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1210\/jc.2003-030596","article-title":"Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol\/cortisone metabolite ratios in men with fatty liver","volume":"88","author":"Westerbacka","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000049972","article-title":"Insulin resistance in nonobese patients with polycystic ovary syndrome","volume":"55","author":"Toprak","year":"2001","journal-title":"Horm Res"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1530\/acta.0.1110075","article-title":"Sex steroids and steroid binding proteins in female alcoholic liver disease","volume":"111","author":"Carlstr\u00f6m","year":"1986","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"10087","DOI":"10.1158\/0008-5472.CAN-07-1646","article-title":"Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha","volume":"67","author":"Buchanan","year":"2007","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/j.yexcr.2006.04.020","article-title":"Human SGT interacts with Bag-6\/Bat-3\/Scythe and cells with reduced levels of either protein display persistence of few misaligned chromosomes and mitotic arrest","volume":"312","author":"Winnefeld","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.bbrc.2006.03.090","article-title":"SGT, a Hsp90beta binding partner, is accumulated in the nucleus during cell apoptosis","volume":"343","author":"Yin","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1093\/humrep\/del222","article-title":"Genomic and post-genomic approaches to polycystic ovary syndrome - progress so far: mini Review","volume":"21","author":"Hughes","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1021\/pr100069e","article-title":"Phosphoproteomic biomarkers predicting histologic nonalcoholic steatohepatitis and fibrosis","volume":"9","author":"Younossi","year":"2010","journal-title":"J Proteome Res"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1210\/jc.2007-1834","article-title":"Impact of obesity on the risk for polycystic ovary syndrome","volume":"93","author":"Yildiz","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bbrc.2010.09.064","article-title":"The obesity-associated Fto gene is a transcriptional coactivator","volume":"401","author":"Wu","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"e1000599","DOI":"10.1371\/journal.pgen.1000599","article-title":"A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene","volume":"5","author":"Church","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.metabol.2009.08.023","article-title":"Association of FTO gene with hyperandrogenemia and metabolic parameters in women with polycystic ovary syndrome","volume":"59","author":"Wehr","year":"2010","journal-title":"Metabolism"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00125-008-1028-6","article-title":"Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome","volume":"51","author":"Barber","year":"2008","journal-title":"Diabetologia"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2337\/db10-0281","article-title":"FTO is increased in muscle during type 2 diabetes and its over-expression in myotubes alters insulin signalling,enhances lipogenesis and ROS production, and induces mitochondrial dysfunction","volume":"60","author":"Bravard","year":"2011","journal-title":"Diabetes"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.2337\/db07-0275","article-title":"Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome","volume":"56","author":"Skov","year":"2007","journal-title":"Diabetes"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s001250051121","article-title":"Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes","volume":"42","author":"Reed","year":"1999","journal-title":"Diabetologia"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00125-005-1673-y","article-title":"Activation of 12-lipoxygenase in proinflammatory cytokine-mediated beta cell toxicity","volume":"48","author":"Chen","year":"2005","journal-title":"Diabetologia"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2337\/db07-0830","article-title":"Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12\/15-lipoxygenase are protected from autoimmune diabetes","volume":"57","author":"McDuffie","year":"2008","journal-title":"Diabetes"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/hep.23928","article-title":"Disruption of the 12\/15-lipoxygenase gene (Alox15) protects hyperlipidemic mice from nonalcoholic fatty liver disease","volume":"52","author":"Mart\u00ednez-Clemente","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/09513590500431458","article-title":"FEM1A is a candidate gene for polycystic ovary syndrome","volume":"21","author":"Maher","year":"2005","journal-title":"Gynecol Endocrinol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1093\/humrep\/den324","article-title":"FEM1A and FEM1B: novel candidate genes for polycystic ovary syndrome","volume":"23","author":"Goodarzi","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.RES.0000204451.88147.96","article-title":"A novel prostaglandin E receptor 4-associated protein participates in antiinflammatory signaling","volume":"98","author":"Takayama","year":"2006","journal-title":"Circ Res"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB84|cit84","first-page":"61","article-title":"Antioxidant effect of prostaglandin E2 in the liver alcoholic steatosis","volume":"64","author":"Mal\u2019tsev","year":"2001","journal-title":"Eksp Klin Farmakol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.etp.2004.10.003","article-title":"PGE2 alleviates kidney and liver damage, decreases plasma renin activity and acute phase response in cirrhotic rats with acute liver damage","volume":"56","author":"Rinc\u00f3n-S\u00e1nchez","year":"2005","journal-title":"Exp Toxicol Pathol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"9692","DOI":"10.1074\/jbc.M709663200","article-title":"Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation","volume":"283","author":"Minami","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2350-11-11","article-title":"Allelic variants in the PHTF1-PTPN22, C12orf30 and CD226 regions as candidate susceptibility factors for the type 1 diabetes in the Estonian population","volume":"11","author":"Douroudis","year":"2010","journal-title":"BMC Med Genet"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/mc.20594","article-title":"Fem1b, a proapoptotic protein, mediates proteasome inhibitor-induced apoptosis of human colon cancer cells","volume":"49","author":"Subauste","year":"2010","journal-title":"Mol Carcinog"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/onc.2009.58","article-title":"Human FEM1B is required for Rad9 recruitment and CHK1 activation in response to replication stress","volume":"28","author":"Sun","year":"2009","journal-title":"Oncogene"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1128\/MCB.25.15.6570-6577.2005","article-title":"Abnormal glucose homeostasis and pancreatic islet function in mice with inactivation of the Fem1b gene","volume":"25","author":"Lu","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"364957","DOI":"10.1155\/2010\/364957","article-title":"Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients","volume":"2010","author":"Tziomalos","year":"2010","journal-title":"Mediators Inflamm"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jc.86.6.2453","article-title":"Low grade chronic inflammation in women with polycystic ovarian syndrome","volume":"86","author":"Kelly","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3904\/kjim.2009.24.4.350","article-title":"Serum C-reactive protein levels in normal-weight polycystic ovary syndrome","volume":"24","author":"Oh","year":"2009","journal-title":"Korean J Intern Med"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0029-7844(03)00233-3","article-title":"Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles","volume":"101","author":"Amato","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.1210\/jc.2005-1002","article-title":"Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance","volume":"90","author":"Puder","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00535-007-2060-x","article-title":"High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH","volume":"42","author":"Yoneda","year":"2007","journal-title":"J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2036.2007.03586.x","article-title":"Adipokines and cytokines in non-alcoholic fatty liver disease","volume":"27","author":"Jarrar","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB98|cit98","article-title":"Total and high-molecular weight adiponectin in women with the polycystic ovary syndrome","author":"Wickham","year":"2010","journal-title":"Metabolism"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB99|cit99","first-page":"19","article-title":"Insulin and insulin resistance","volume":"26","author":"Wilcox","year":"2005","journal-title":"Clin Biochem Rev"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ncpendmet0400","article-title":"The genetics of the polycystic ovary syndrome","volume":"3","author":"Urbanek","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"28359","DOI":"10.1074\/jbc.R300009200","article-title":"In vivo mutagenesis of the insulin receptor","volume":"278","author":"Okamoto","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1210\/jc.86.1.446","article-title":"Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene locus","volume":"86","author":"Tucci","year":"2001","journal-title":"J Clin Endocr Metab"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0015-0282(02)04241-3","article-title":"A C\/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome","volume":"78","author":"Siegel","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB104|cit104","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ymgme.2009.10.013","article-title":"Polymorphisms of the insulin receptor and the insulin receptor substrates genes in polycystic ovary syndrome: a Mendelian randomization meta-analysis","volume":"99","author":"Ioannidis","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"e4274","DOI":"10.1371\/journal.pone.0004274","article-title":"Effect of testosterone on insulin stimulated IRS1 Ser phosphorylation in primary rat myotubes - a potential model for PCOS-related insulin resistance","volume":"4","author":"Allemand","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB106|cit106","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1172\/JCI23187","article-title":"Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism","volume":"115","author":"Taniguchi","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB107|cit107","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1210\/en.2005-0850","article-title":"Minireview: recent developments in the regulation of glucose transporter-4 traffic: new signals, locations, and partners","volume":"146","author":"Ishiki","year":"2005","journal-title":"Endocrinology"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB108|cit108","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2119\/2005-00029.Saltiel","article-title":"Insulin signaling and the regulation of glucose transport","volume":"10","author":"Chang","year":"2004","journal-title":"Mol Med"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB109|cit109","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.2337\/dc08-0532","article-title":"First evidence of genetic association between AKT2 and polycystic ovary syndrome","volume":"31","author":"Goodarzi","year":"2008","journal-title":"Diab Care"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB110|cit110","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10815-007-9156-3","article-title":"PTEN and Akt expression during growth of human ovarian follicles","volume":"24","author":"Goto","year":"2007","journal-title":"J Assist Reprod Genet"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.2353\/ajpath.2010.090931","article-title":"The critical role of AKT2 in hepatic steatosis induced by PTEN loss","volume":"176","author":"He","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB112|cit112","first-page":"315","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis","volume":"119","author":"Semple","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cmet.2009.10.004","article-title":"Akt2 is required for hepatic lipid accumulation in models of insulin resistance","volume":"10","author":"Leavens","year":"2009","journal-title":"Cell Metab"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB114|cit114","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1530\/EJE-07-0857","article-title":"Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome","volume":"158","author":"Jensterle","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1007\/s11695-010-0171-6","article-title":"Hepatic gene networks in morbidly obese patients with nonalcoholic fatty liver disease","volume":"20","author":"Gawrieh","year":"2010","journal-title":"Obes Surg"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB116|cit116","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/GCO.0b013e32833e1264","article-title":"Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update","volume":"22","author":"Katsiki","year":"2010","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB117|cit117","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1530\/EJE-10-0692","article-title":"Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome","volume":"164","author":"Pasquali","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB118|cit118","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/humrep\/dei311","article-title":"Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB119|cit119","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1001\/jama.2008.641","article-title":"Pregnancy and fertility following bariatric surgery: a systematic review","volume":"300","author":"Maggard","year":"2008","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB120|cit120","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1381\/096089206778870148","article-title":"The impact of bariatric surgery on menstrual patterns","volume":"16","author":"Teitelman","year":"2006","journal-title":"Obes Surg"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB121|cit121","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1210\/jc.2005-1490","article-title":"The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery","volume":"90","author":"Escobar-Morreale","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB122|cit122","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1530\/REP-09-0568","article-title":"The adverse effects of obesity on conception and implantation","volume":"140","author":"Brewer","year":"2010","journal-title":"Reproduction"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB123|cit123","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.23623","article-title":"A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease","volume":"52","author":"Musso","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB124|cit124","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB125|cit125","first-page":"CD007340","article-title":"Bariatric surgery for non-alcoholic steatohepatitis in obese patients","volume":"20","author":"Chavez-Tapia","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1365-2036.2011.04579.x-BIB126|cit126","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000282102","article-title":"Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease","volume":"28","author":"Weiner","year":"2010","journal-title":"Dig Dis"}],"container-title":["Alimentary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2011.04579.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2036.2011.04579.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T19:40:07Z","timestamp":1637178007000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2011.04579.x"}},"subtitle":["Systematic review: polycystic ovary syndrome, NAFLD and bariatric surgery"],"short-title":[],"issued":{"date-parts":[[2011,1,20]]},"references-count":126,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04579.x","relation":{},"ISSN":["0269-2813"],"issn-type":[{"value":"0269-2813","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,20]]}}}